Showing results (261-270 of 466) with videos related to

Sort By:
Pageof 47
Cancer|August 2, 2024
Inotuzumab ozogamicin in adult acute lymphoblastic leukemia: Development, current status, and future directionsHagop M Kantarjian, Nicolas Boissel, Cristina Papayannidis, et al.
British Journal of Haematology|March 1, 1996
Analysis of p53 and mdm-2 expression in 18 patients with Sézary syndromeD I Marks, E C Vonderheid, B W Kurz, et al.
Clinical Pharmacology and Therapeutics|May 7, 2010
Safety and feasibility of autologous bone marrow cellular therapy in relapsing-progressive multiple sclerosisC M Rice, E A Mallam, A L Whone, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 28, 2014
Conditioning chemotherapy dose adjustment in obese patients: a review and position statement by the American Society for Blood and Marrow Transplantation practice guideline committeeJoseph Bubalo, Paul A Carpenter, Navneet Majhail, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 29, 2000
T cell-depleted unrelated donor bone marrow transplantation for acute myeloid leukemiaD I Marks, J M Bird, K Vettenranta, et al.
BMJ Open|September 13, 2015
Repeat infusion of autologous bone marrow cells in multiple sclerosis: protocol for a phase I extension study (SIAMMS-II)Claire M Rice, David I Marks, Peter Walsh, et al.
BMJ Open|June 1, 2023
ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remissionDavid I Marks, Anna Castleton, Eduardo Olavarria, et al.
Bone Marrow Transplantation|August 26, 1998
Double T cell depletion of bone marrow using sequential positive and negative cell immunoaffinity or CD34+ cell selection followed by Campath-1M; effect on CD34+ cells and progenitor cell recoveriesE Clarke, M N Potter, G Hale, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 11, 2019
A Phase 3 Randomized Study of Remestemcel-L versus Placebo Added to Second-Line Therapy in Patients with Steroid-Refractory Acute Graft-versus-Host DiseasePartow Kebriaei, Jack Hayes, Andrew Daly, et al.
Bone Marrow Transplantation|June 26, 2007
The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR studyS Feyler, H M Prince, R Pearce, et al.
Pageof 47